Bioartificial liver with reprogrammed hepatocytes ready for prime time

In this issue, Wang et al.1 provide evidence of the pre-clinical as well as the clinical utility of in vitro-generated directly reprogrammed human hepatocytes in bioartificial liver. This approach will help offer patients a more curative surgical therapy for liver cancer and improve survival rates....

Full description

Saved in:
Bibliographic Details
Published inCell stem cell Vol. 30; no. 5; pp. 504 - 506
Main Authors Li, Ruomeng, Balakrishnan, Asha, Ott, Michael, Sharma, Amar Deep
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 04.05.2023
Subjects
Hepatocytes
Humans
Liver
Liver Neoplasms
Liver, Artificial
Online AccessGet full text

Cover

More Information
Summary:In this issue, Wang et al.1 provide evidence of the pre-clinical as well as the clinical utility of in vitro-generated directly reprogrammed human hepatocytes in bioartificial liver. This approach will help offer patients a more curative surgical therapy for liver cancer and improve survival rates. In this issue, Wang et al.1 provide evidence of the pre-clinical as well as the clinical utility of in vitro-generated directly reprogrammed human hepatocytes in bioartificial liver. This approach will help offer patients a more curative surgical therapy for liver cancer and improve survival rates.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1934-5909
1875-9777
DOI:10.1016/j.stem.2023.04.008